Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

In Vitro Evaluation of the Fresenius Kabi CATSmart Autotransfusion System.

Publication ,  Journal Article
Alberts, M; Groom, RC; Walczak, R; Kramer, R; Karpiel, A; Dieter, J; Sheth, L; Greene, NH; Jooste, EH
Published in: J Extra Corpor Technol
June 2017

Use of autotransfusion systems to collect, wash, and concentrate shed blood during surgical procedures is a widely used method for reducing postoperative anemia and the need for blood transfusions. The aim of this study was to evaluate the CATSmart Continuous Autotransfusion System wash program performance with small (200 or 700 mL) and large volumes (1,000 mL) of shed blood and to determine non-inferiority of the CATSmart to the C.A.T.S plus system. Human whole blood was collected in citrate phosphate dextrose, diluted, and divided into two aliquots to be processed as a pair using the C.A.T.S plus and CATSmart systems with their corresponding wash programs: low-volume, high quality/smart, or emergency wash. Final packed red cell product was analyzed for red blood cell (RBC), white blood cell, and platelet counts; hemoglobin; hemolysis; RBC recovery rates; and elimination of albumin, total protein, and potassium. The mean hematocrit (HCT) after processing with CATSmart and C.A.T.S plus systems were 59.63% and 57.71%, respectively. The calculated overall RBC recovery rates on the CATSmart and C.A.T.S plus systems were 85.41% and 84.99%, respectively. Elimination of albumin (97.5%, 98.0%), total proteins (97.1%, 97.5%), and potassium (92.1%, 91.9%) were also calculated for the CATSmart and C.A.T.S plus systems. The CATSmart and C.A.T.S plus systems both provided a high-quality product in terms of HCT, protein elimination, and hemolysis rates across the range of tested shed blood volumes and all wash programs. The study was able to confirm the CATSmart is non-inferior to the C.A.T.S plus system.

Duke Scholars

Published In

J Extra Corpor Technol

ISSN

0022-1058

Publication Date

June 2017

Volume

49

Issue

2

Start / End Page

107 / 111

Location

France

Related Subject Headings

  • Specimen Handling
  • Robotics
  • Respiratory System
  • Operative Blood Salvage
  • Humans
  • Equipment Failure Analysis
  • Equipment Design
  • Blood Transfusion, Autologous
  • Blood Component Removal
  • Blood Cells
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Alberts, M., Groom, R. C., Walczak, R., Kramer, R., Karpiel, A., Dieter, J., … Jooste, E. H. (2017). In Vitro Evaluation of the Fresenius Kabi CATSmart Autotransfusion System. J Extra Corpor Technol, 49(2), 107–111.
Alberts, Melissa, Robert C. Groom, Richard Walczak, Robert Kramer, Adrienne Karpiel, Jeanette Dieter, Lisa Sheth, Nathaniel H. Greene, and Edmund H. Jooste. “In Vitro Evaluation of the Fresenius Kabi CATSmart Autotransfusion System.J Extra Corpor Technol 49, no. 2 (June 2017): 107–11.
Alberts M, Groom RC, Walczak R, Kramer R, Karpiel A, Dieter J, et al. In Vitro Evaluation of the Fresenius Kabi CATSmart Autotransfusion System. J Extra Corpor Technol. 2017 Jun;49(2):107–11.
Alberts, Melissa, et al. “In Vitro Evaluation of the Fresenius Kabi CATSmart Autotransfusion System.J Extra Corpor Technol, vol. 49, no. 2, June 2017, pp. 107–11.
Alberts M, Groom RC, Walczak R, Kramer R, Karpiel A, Dieter J, Sheth L, Greene NH, Jooste EH. In Vitro Evaluation of the Fresenius Kabi CATSmart Autotransfusion System. J Extra Corpor Technol. 2017 Jun;49(2):107–111.

Published In

J Extra Corpor Technol

ISSN

0022-1058

Publication Date

June 2017

Volume

49

Issue

2

Start / End Page

107 / 111

Location

France

Related Subject Headings

  • Specimen Handling
  • Robotics
  • Respiratory System
  • Operative Blood Salvage
  • Humans
  • Equipment Failure Analysis
  • Equipment Design
  • Blood Transfusion, Autologous
  • Blood Component Removal
  • Blood Cells